Retatrutide: Metabolic Promise Requires Personalized Clinical Oversight
Retatrutide is showing strong promise for metabolic health, delivering meaningful weight loss and improvements in insulin resistance, visceral fat, and inflammatory markers.
As a triple agonist (GLP-1/GIP/GCG), it can also cause side effects—nausea, delayed gastric emptying, and, in some cases, immune-related responses.
These risks are not reasons to avoid treatment, but to pursue it with clinical expertise and individualized care. At Extension, we provide medical oversight and personalized protocols to help you navigate retatrutide safely and effectively.
